Cargando...
Cost-effectiveness of esketamine nasal spray for patients with treatment-resistant depression in the United States
OBJECTIVE: The aim of this study was to estimate the cost-effectiveness of esketamine, a novel intranasally-dosed antidepressant, for patients in the United States with treatment-resistant depression. METHODS: A decision-analytic model, parameterized with efficacy data from phase III randomized tria...
Guardado en:
| Publicado en: | Psychiatr Serv |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920520/ https://ncbi.nlm.nih.gov/pubmed/32631129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ps.201900625 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|